Infliximab trials for Crohn's disease

7 recruiting trials study Infliximab in trials listing Crohn's disease in our tracked data. This is not a statement that it treats the condition.

Recruiting trials

Phase breakdown

Phase 2 1Phase 3 1Phase 4 4Not applicable 2

Combined Immunosuppression for Pediatric Crohn's Disease
NCT05043870 · Phase: Phase 4 · Ages: 6 Years to 18 Years · Sex: All (male and female) · 1 location
Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Disease
NCT07694674 · Phase: Not specified · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease
NCT06758024 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
Pharmacokinetic Infliximab Data in Pediatric Crohn's Disease
NCT05552287 · Phase: Phase 4 · Ages: 1 Year to 15 Years · Sex: All (male and female) · 1 location
Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
NCT05906576 · Phase: Phase 4 · Ages: 6 Years to 17 Years · Sex: All (male and female) · 1 location
Precise Infliximab Exposure and Pharmacodynamic Control
NCT05660746 · Phase: Phase 2, Phase 3 · Ages: 6 Years to 22 Years · Sex: All (male and female) · 11 locations
Subcutaneous Infliximab After A Previous Intravenous Dose Optimization
NCT06113913 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 30 locations